A latent profile analysis of age of onset in trichotillomania.


Journal

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
ISSN: 1547-3325
Titre abrégé: Ann Clin Psychiatry
Pays: United States
ID NLM: 8911021

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 27 5 2020
Statut: ppublish

Résumé

Trichotillomania (TTM) onset may occur across the lifespan; however, adolescent onset is most frequently reported. Several studies have explored clinical differences between TTM age-of-onset groups with mixed results. We investigated empirically defined age-of-onset groups in adults with TTM, and clinical differences between groups. Participants included 1,604 adult respondents to an internet survey who endorsed DSM-IV-TR TTM criteria. Latent profile analysis was performed to identify TTM age-of-onset subgroups, which were then compared on demographic and clinical features. The most optimal model was a 2-class solution comprised of a large group with average TTM onset during adolescence (n = 1,539; 95.9% of the sample; mean age of onset = 12.4) and a small group with average onset in middle adulthood (n = 65; 4.1% of the sample; mean age of onset = 35.6). The late-onset group differed from the early-onset group on several clinical variables (eg, less likely to report co-occurring bodyfocused repetitive behaviors). Findings suggest the presence of at least 2 distinct TTM age-of-onset subgroups: an early-onset group with onset during adolescence, and a late-onset group with onset in middle adulthood. Future research is needed to further validate these subgroups and explore their clinical utility.

Sections du résumé

BACKGROUND
Trichotillomania (TTM) onset may occur across the lifespan; however, adolescent onset is most frequently reported. Several studies have explored clinical differences between TTM age-of-onset groups with mixed results. We investigated empirically defined age-of-onset groups in adults with TTM, and clinical differences between groups.
METHODS
Participants included 1,604 adult respondents to an internet survey who endorsed DSM-IV-TR TTM criteria. Latent profile analysis was performed to identify TTM age-of-onset subgroups, which were then compared on demographic and clinical features.
RESULTS
The most optimal model was a 2-class solution comprised of a large group with average TTM onset during adolescence (n = 1,539; 95.9% of the sample; mean age of onset = 12.4) and a small group with average onset in middle adulthood (n = 65; 4.1% of the sample; mean age of onset = 35.6). The late-onset group differed from the early-onset group on several clinical variables (eg, less likely to report co-occurring bodyfocused repetitive behaviors).
CONCLUSIONS
Findings suggest the presence of at least 2 distinct TTM age-of-onset subgroups: an early-onset group with onset during adolescence, and a late-onset group with onset in middle adulthood. Future research is needed to further validate these subgroups and explore their clinical utility.

Identifiants

pubmed: 31369656
pii: acp_3103c
pmc: PMC9528732
mid: NIHMS1837644

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-178

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH113884
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001437
Pays : United States

Références

Compr Psychiatry. 2018 Nov;87:46-52
pubmed: 30199665
J Clin Psychiatry. 2006 Dec;67(12):1877-88
pubmed: 17194265
J Anxiety Disord. 2016 Jan;37:21-9
pubmed: 26590429
Psychol Rep. 2003 Feb;92(1):228-30
pubmed: 12674287
Clin Psychol Rev. 2012 Nov;32(7):618-29
pubmed: 22917741
Clin Psychol Rev. 2013 Aug;33(6):745-62
pubmed: 23792470
J Psychiatr Res. 2013 Dec;47(12):1870-5
pubmed: 24084228
Prim Care Companion CNS Disord. 2012;14(4):
pubmed: 23251869
Behav Res Ther. 2008 Mar;46(3):345-57
pubmed: 18249363
Psychiatr Clin North Am. 2014 Sep;37(3):301-17
pubmed: 25150564
Clin Psychol Rev. 2011 Nov;31(7):1083-100
pubmed: 21820387
Schizophr Res. 2004 Nov 1;71(1):35-41
pubmed: 15374570
Psychother Psychosom. 1995;64(3-4):141-5
pubmed: 8657844
Child Psychiatry Hum Dev. 2009 Mar;40(1):153-67
pubmed: 18780180
J Anxiety Disord. 2017 Aug;50:47-51
pubmed: 28554154
Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):664-7
pubmed: 23988234
Behav Res Ther. 2002 Nov;40(11):1305-15
pubmed: 12384325
J Nerv Ment Dis. 2010 Dec;198(12):896-900
pubmed: 21135642
Child Psychiatry Hum Dev. 2014 Feb;45(1):24-31
pubmed: 23564261
Int J Psychiatry Med. 1997;27(2):93-105
pubmed: 9565717
Psychiatry Res. 2011 Jun 30;188(1):34-9
pubmed: 21131056
J Anxiety Disord. 2010 Mar;24(2):196-202
pubmed: 19932593
Psychiatry Res. 2009 Jan 30;165(1-2):163-74
pubmed: 19042030
Dermatol Ther. 2008 Jan-Feb;21(1):13-21
pubmed: 18318881
Clin Child Psychol Psychiatry. 2008 Jul;13(3):409-18
pubmed: 18783123
J Affect Disord. 2017 Jul;216:109-116
pubmed: 27692699

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH